Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR7 | Q9NYK1 | 8/20 | 0.48 |
| ▸ | TLR9 | Q9NR96 | 4/20 | 0.43 |
| ▸ | MAPT | P10636 | 4/20 | 0.43 |
| ▸ | MEN1 | O00255 | 3/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.43 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.43 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.40 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.40 |
| ▸ | P2RY12 | Q9H244 | 1/20 | 0.40 |
| ▸ | APP | P05067 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14135761 | 0.88 | TLR7 (0.44) | TLR7TLR9MAPTPOLBSMN1; SMN2 | |
| SCHEMBL5044889 | 0.85 | TLR7 (0.43) | TLR7TLR9MAPTPOLBSMN1; SMN2 | |
| SCHEMBL5045843 | 0.82 | ESR1 (0.55) | MAPTMEN1KMT2ALMNANPSR1 | |
| SCHEMBL5041476 | 0.81 | MAPT (0.43) | TLR7TLR9MAPTMEN1KMT2A | |
| SCHEMBL5042502 | 0.81 | TLR7 (0.39) | TLR7TLR9MAPTMEN1KMT2A | |
| SCHEMBL5049477 | 0.80 | MAPT (0.42) | TLR7MAPTMEN1KMT2ALMNA | |
| SCHEMBL14095569 | 0.79 | MAPT (0.41) | TLR7TLR9MAPTMEN1KMT2A | |
| SCHEMBL5045089 | 0.79 | MEN1 (0.57) | MAPTMEN1KMT2ALMNANPSR1 | |
| SCHEMBL5042031 | 0.73 | MAPT (0.51) | TLR9MAPTMEN1KMT2ALMNA | |
| SCHEMBL14095576 | 0.73 | MAPT (0.49) | MAPTMEN1KMT2ALMNANPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7414138-B2 | Benzoxazole and benzodiazole UV-A sunscreens | DSM IP ASSETS B.V. (NL) | 2008-08-19 | — | — | US | claimed |
| EP-1515694-A1 | BENZOXAZOLE AND BENZODIAZOLE UV-A SUNSCREENS | DSM IP Assets B.V. (NL) | 2005-03-23 | — | — | EP | claimed |
| WO-2004000256-A1 | BENZOXAZOLE AND BENZODIAZOLE UV-A SUNSCREENS | DSM IP ASSETS B.V. (NL) | 2003-12-31 | — | — | WO | claimed |
| US-7414138-B2 | Benzoxazole and benzodiazole UV-A sunscreens | DSM IP ASSETS B.V. (NL) | 2008-08-19 | — | — | US | disclosed |
| US-7414138-B2 | Benzoxazole and benzodiazole UV-A sunscreens | DSM IP ASSETS B.V. (NL) | 2008-08-19 | — | — | US | disclosed |
| US-20050260144-A1 | Benzoxazole and benzodiazole uv-a sunscreens | DSM IP ASSETS B.V. (NL) | 2005-11-24 | — | — | US | disclosed |
| EP-1515694-A1 | BENZOXAZOLE AND BENZODIAZOLE UV-A SUNSCREENS | DSM IP Assets B.V. (NL) | 2005-03-23 | — | — | EP | disclosed |
| WO-2004000256-A1 | BENZOXAZOLE AND BENZODIAZOLE UV-A SUNSCREENS | DSM IP ASSETS B.V. (NL) | 2003-12-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050260144-A1 | Benzoxazole and benzodiazole uv-a sunscreens | SUN2, CYP27B1, ERCC4 | TLR7 2407/4885TLR9 3618/4885MAPT 543/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.